Trials / Unknown
UnknownNCT06108778
Incidence of Metabolic Disorders in Neonatal Convulsions
Adescriptive Study on Incidence of Metabolic Disorders in Neonatal Convulsions
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 115 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 1 Day – 28 Days
- Healthy volunteers
- —
Summary
Describe the incidence of metabolic disorders in neonatal convulsions affecting neonates at NICU Describe types of metabolic disorders causing neonatal convulsions
Detailed description
Neonates are susceptible to seizures due to several physiologic factors and combination of risks that are uniquely associated with gestation, delivery,and the immediate postnatal period. Neonatal seizures can be challenging to identify therefore itis imperative that clinicians have ahigh degree of suspicion for seizures based on the clinical history or the presence of encephalopathy with or without paroxysmal abnormal movements. Acute symptomatic neonatal seizures are due to an acute brain injury, whereas neonatal onset\_epilepsy may be due to underlying structural, metabolic ,or genetic disorders.Early identification and treatment are likely important for long term outcomes in acute symptomatic seizures though additional studies are needed to understand optimal seizure control metrics and the ideal duration of treatment. seizures may be the first and the major presenting feature of an inborn error of metabolism. seizures may be preceded by other major symptoms by areduced level of consciousness in achild with an organic acidemia or urea cycle defect or by loss of skills ,progressive weakness ,ataxia ,and upper motor signs in achild with lysosomal storage disorder or peroxisomal leukodystrophy.the metabolic causes of seizure vary according to age at presentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MRI | Investigations as CT,MRI.serum ammonia and lactate |
Timeline
- Start date
- 2023-11-25
- Primary completion
- 2024-12-25
- Completion
- 2025-02-25
- First posted
- 2023-10-31
- Last updated
- 2023-11-07
Source: ClinicalTrials.gov record NCT06108778. Inclusion in this directory is not an endorsement.